The planned Phase 3 study is a randomized, placebo-controlled, double-masked, multicenter clinical trial designed to evaluate the safety and efficacy of TRIESENCE in patients undergoing cataract ...
Adding LAG-3 or TIGIT ICIs to enfortumab vedotin + pembrolizumab did not improve efficacy in pts with locally advanced or ...
Wayne Memorial Hospital in Honesdale is pledging to maintain its care level while dropping its label as a Level IV trauma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results